Erratum: A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study) (Japanese Journal of Clinical Oncology DOI: 10.1093/jjco/hyab101)